The 2 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 11.00, with a high estimate of 13.00 and a low estimate of 9.00. The median estimate represents a +653.42% increase from the last price of 1.46.
The current consensus among 2 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.47
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.